Panthera Biopartners
CRO
Seed Investment
2020 - 2022
www.panthera-bio.com
Panthera recruits patients and runs clinical trials on behalf of Contract Research Organisations and pharmaceutical companies developing new drugs. It has a specialism in oncology, NASH, neurology and vaccines.
The business received a seed investment from GM&C to help establish new sites, including in Rochdale, and secure its first customers.
Within two years, Panthera had become one of the fastest growing companies in the UK securing millions of pounds of clinical trial contracts. GM&C exited when the company raised £10m in growth capital for further expansion, resulting in a 3.3x cash return and an IRR of 115.6%.